• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与西罗莫司洗脱支架相比,依维莫司洗脱支架的血管造影结果:来自西罗莫司洗脱支架与依维莫司洗脱支架随机评估试验(RESET)的血管造影子研究。

Angiographic findings of everolimus-eluting as compared to sirolimus-eluting stents: angiographic sub-study from the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET).

作者信息

Kozuma Ken, Kimura Takeshi, Kadota Kazushige, Suwa Satoru, Kimura Kazuo, Iwabuchi Masashi, Kawai Kazuya, Miyazawa Akiyoshi, Kawamura Masaki, Nakao Koichi, Asano Ryuta, Yamamoto Takashi, Suzuki Nobuaki, Aoki Jiro, Kyono Hiroyuki, Nakazawa Gaku, Tanabe Kengo, Morino Yoshihiro, Igarashi Keiichi

机构信息

Department of Cardiology, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan,

出版信息

Cardiovasc Interv Ther. 2013 Oct;28(4):344-51. doi: 10.1007/s12928-013-0179-7. Epub 2013 Apr 23.

DOI:10.1007/s12928-013-0179-7
PMID:23608784
Abstract

Several recent randomized trials comparing everolimus-eluting stent (EES) and sirolimus-eluting stent (SES) reported similar clinical outcomes. This study was aimed to clarify the differences in the angiographic findings of EES as compared to SES. Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial is a prospective multicenter randomized open-label trial comparing EES with SES in Japan. From February to July 2010, 3197 patients were randomly assigned to receive either EES or SES. Of these, angiographic sub-study enrolled 571 patients (EES 285 patients, SES 286 patients). Angiograms were assessed qualitatively and quantitatively at procedure and at 8-12 months in the independent core angiographic laboratory. Late loss of the proximal edges tended to be greater in the EES group than that in the SES group (0.12 ± 0.49 vs. 0.04 ± 0.43 mm, P = 0.05), although late loss in the other segments was similar between the 2 groups. Edge restenosis was mainly observed in EES group, whereas body restenosis was demonstrated in half of SES group. Stent fracture was observed only in the SES group (1.5 %), and peri-stent contrast staining (PSS) tended to be more frequently observed in the SES group than in the EES group (3.6 and 1.5 %, P = 0.18). Restenotic response in the proximal edge was more prominent in the EES group as compared to the SES group. Abnormal angiographic findings such as stent fracture and PSS tended to be more frequent in the SES group.

摘要

最近几项比较依维莫司洗脱支架(EES)和西罗莫司洗脱支架(SES)的随机试验报告了相似的临床结果。本研究旨在阐明EES与SES在血管造影结果上的差异。西罗莫司洗脱支架与依维莫司洗脱支架试验的随机评估是一项前瞻性多中心随机开放标签试验,在日本比较EES和SES。2010年2月至7月,3197例患者被随机分配接受EES或SES。其中,血管造影亚研究纳入了571例患者(EES组285例,SES组286例)。在独立的核心血管造影实验室对血管造影进行了定性和定量评估,分别在手术时和8至12个月时进行。EES组近端边缘的晚期丢失往往比SES组更大(0.12±0.49 vs.0.04±0.43 mm,P = 0.05),尽管两组其他节段的晚期丢失相似。边缘再狭窄主要在EES组观察到,而体部再狭窄在SES组中有一半出现。仅在SES组观察到支架断裂(1.5%),SES组比EES组更频繁地观察到支架周围造影剂染色(PSS)(3.6%和1.5%,P = 0.18)。与SES组相比,EES组近端边缘的再狭窄反应更明显。SES组中支架断裂和PSS等异常血管造影结果往往更频繁。

相似文献

1
Angiographic findings of everolimus-eluting as compared to sirolimus-eluting stents: angiographic sub-study from the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET).与西罗莫司洗脱支架相比,依维莫司洗脱支架的血管造影结果:来自西罗莫司洗脱支架与依维莫司洗脱支架随机评估试验(RESET)的血管造影子研究。
Cardiovasc Interv Ther. 2013 Oct;28(4):344-51. doi: 10.1007/s12928-013-0179-7. Epub 2013 Apr 23.
2
Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).比较依维莫司洗脱和西罗莫司洗脱冠状动脉支架:随机评价西罗莫司洗脱与依维莫司洗脱支架试验(RESET)的 1 年结果。
Circulation. 2012 Sep 4;126(10):1225-36. doi: 10.1161/CIRCULATIONAHA.112.104059. Epub 2012 Jul 23.
3
Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.依维莫司洗脱支架与西罗莫司洗脱支架治疗经皮冠状动脉介入治疗患者的效果比较:EXCELLENT(依维莫司洗脱 Xience/Promus 支架与西罗莫司洗脱 Cypher 支架减少支架置入后晚期管腔丢失的疗效)随机试验。
J Am Coll Cardiol. 2011 Oct 25;58(18):1844-54. doi: 10.1016/j.jacc.2011.07.031.
4
Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial.比较依维莫司洗脱支架和西罗莫司洗脱支架治疗长段冠状动脉病变患者的疗效:一项随机 LONG-DES-III(经皮治疗长段 native 冠状动脉病变的药物洗脱支架-III 试验)研究。
JACC Cardiovasc Interv. 2011 Oct;4(10):1096-103. doi: 10.1016/j.jcin.2011.05.024.
5
Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial.依维莫司和西罗莫司洗脱冠状动脉支架置入术后的长期临床结局:随机评价西罗莫司洗脱支架与依维莫司洗脱支架试验的最终 3 年随访。
Circ Cardiovasc Interv. 2014 Jun;7(3):343-54. doi: 10.1161/CIRCINTERVENTIONS.113.001322. Epub 2014 May 6.
6
Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.糖尿病患者接受依维莫司洗脱支架和西罗莫司洗脱支架植入后的内膜增生与血管重塑:随机糖尿病与药物洗脱支架(DiabeDES)IV血管内超声试验
Catheter Cardiovasc Interv. 2014 May 1;83(6):864-72. doi: 10.1002/ccd.25180. Epub 2013 Sep 30.
7
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.依维莫司洗脱支架与紫杉醇洗脱支架的随机对照比较:来自Xience V依维莫司洗脱冠状动脉支架系统治疗初发原发性冠状动脉病变患者的临床评估(SPIRIT)III试验的两年临床随访
Circulation. 2009 Feb 10;119(5):680-6. doi: 10.1161/CIRCULATIONAHA.108.803528. Epub 2009 Jan 26.
8
One-year clinical outcomes of everolimus- versus sirolimus-eluting stents in patients with acute myocardial infarction.依维莫司洗脱支架与西罗莫司洗脱支架治疗急性心肌梗死患者的一年临床结局
Int J Cardiol. 2014 Oct 20;176(3):583-8. doi: 10.1016/j.ijcard.2014.08.049. Epub 2014 Aug 19.
9
Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: a randomized comparison in setting of ISAR-TEST-4 trial.第二代与第一代“利莫斯”洗脱支架用于冠心病糖尿病患者:ISAR-TEST-4试验背景下的随机对照比较
Catheter Cardiovasc Interv. 2013 Nov 15;82(6):E769-76. doi: 10.1002/ccd.24741. Epub 2013 Jun 11.
10
Occurrence of late acquired peri-stent contrast staining: comparison between sirolimus-eluting stents and everolimus-eluting stents.晚期获得性支架周围造影剂染色的发生情况:西罗莫司洗脱支架与依维莫司洗脱支架的比较
Int Heart J. 2012;53(3):165-9. doi: 10.1536/ihj.53.165.

引用本文的文献

1
Tudor-SN exacerbates pathological vascular remodeling by promoting the polyubiquitination of PTEN via NEDD4-1.Tudor-SN 通过促进 NEDD4-1 对 PTEN 的多泛素化来加剧病理性血管重构。
J Biomed Sci. 2024 Sep 5;31(1):88. doi: 10.1186/s12929-024-01076-9.
2
Coronary Stent Fracture Causing Myocardial Infarction: Case Report and Review of Literature.冠状动脉支架断裂导致心肌梗死:病例报告及文献综述
Rev Cardiovasc Med. 2022 Nov 16;23(11):384. doi: 10.31083/j.rcm2311384. eCollection 2022 Nov.
3
Combinational Growth Factor and Gas Delivery for Thrombosis Prevention.
联合生长因子与气体输送预防血栓。
Biomolecules. 2022 Nov 19;12(11):1715. doi: 10.3390/biom12111715.
4
Incidence of coronary drug-eluting stent fracture: A systematic review and meta-analysis.冠状动脉药物洗脱支架断裂的发生率:一项系统评价与荟萃分析。
Front Cardiovasc Med. 2022 Aug 23;9:925912. doi: 10.3389/fcvm.2022.925912. eCollection 2022.
5
Mechanisms of drug-eluting stent restenosis.药物洗脱支架再狭窄的机制。
Cardiovasc Interv Ther. 2021 Jan;36(1):23-29. doi: 10.1007/s12928-020-00734-7. Epub 2020 Nov 21.
6
Impact of Angiographic Residual Stenosis on Clinical Outcomes After New-Generation Drug-Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT Trials.新一代药物洗脱支架置入后血管造影残余狭窄对临床结局的影响:RESET 和 NEXT 试验的 pooled 分析结果。
J Am Heart Assoc. 2018 Jun 30;7(13):e008718. doi: 10.1161/JAHA.118.008718.
7
Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature.药物洗脱支架治疗恶性气道阻塞:文献综述。
J Cancer. 2016 Jan 13;7(4):377-90. doi: 10.7150/jca.13611. eCollection 2016.
8
Side branch healing patterns of the Tryton dedicated bifurcation stent: a 1-year optical coherence tomography follow-up study.Tryton专用分叉支架的分支愈合模式:一项为期1年的光学相干断层扫描随访研究。
Int J Cardiovasc Imaging. 2014 Dec;30(8):1445-56. doi: 10.1007/s10554-014-0504-y. Epub 2014 Jul 26.
9
Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis.向心脏病专家学习,开发针对mTOR通路的用于肺部的洗脱支架;气管狭窄的未来概念。
J Mol Genet Med. 2013 Aug 26;7:65. doi: 10.4172/1747-0862.1000065.